HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW to Recommend Use of ReQuip CR Tablets
August 23, 2012
-
REGULATORY PMDA’s Regulatory Consultation Service Off to Good Start, but More Effort Needed to Promote Face-to-Face Advisory Meetings: Dr Isobe
August 22, 2012
-
BUSINESS Mediscience Stepping Up Athlete Recruitments as CMRs
August 21, 2012
-
REGULATORY Healthcare to Receive Priority in FY2013 Draft Budget Request Guidelines
August 21, 2012
-
BUSINESS DSP to Set Up Cancer Institute Led by CEO of Its US Subsidiary BBI
August 21, 2012
-
REGULATORY PAFSC’s 1st Committee to Review 7 Products Including Bayer Yakuhin’s AMD Drug on Aug. 31
August 20, 2012
-
BUSINESS “Sense of Achievement” Motivates MRs; Brach Managers to Be Blamed for Miscommunications: Survey of Managers
August 20, 2012
-
REGULATORY US Regulation Could Delay Introduction of PBRER as ICH Standard
August 17, 2012
-
REGULATORY MHLW Approves Allegra Generics of 3 Companies for Listing in December
August 16, 2012
-
BUSINESS Differences in Concurrent-Use Indications for DPP-4 Inhibitors to Be Eliminated through Special Clinical Trials
August 15, 2012
-
REGULATORY Neo-Morgan Laboratory Developing a Variety of Organisms Using “Disparity Mutagenesis Technology”
August 14, 2012
-
BUSINESS Business Strategies of Generics Manufacturers Become Evident Ahead of Upcoming Round of Patent Expiries
August 13, 2012
-
REGULATORY MHLW to Include Generic Drug Share Targets in Next 5-Year Medical Spending Optimization Plans in Response to Requests by Insurers
August 10, 2012
-
ORGANIZATION PI Forum to Make Proposals to Promote R&D, Make Pharmaceuticals Japan’s Key Industry: Chairman Toyoda
August 9, 2012
-
BUSINESS Daiichi Sankyo to Strengthen Cardiovascular Field by Comarketing Diabetes Treatments, Focusing on SGLT-2 Inhibitor
August 8, 2012
-
REGULATORY MOF Wants Generic Drug Share to Reach European, US Levels: Budget Examiner Shinkawa
August 8, 2012
-
BUSINESS 6 Listed Wholesalers Post Low Price Settlement Rates as of End-June, Showing Declines Compared to 2 Years Earlier
August 7, 2012
-
BUSINESS Astellas to “Seek Every Opportunity” for Domestic Vaccine Business, Including Alliances with Foreign Companies
August 6, 2012
-
BUSINESS DSP to Establish Sales Force for Anticancer Drugs in North America
August 3, 2012
-
BUSINESS Daiichi Sankyo: April-June Nexium Sales 6% of Full-Year Target, Set to Boost Promotion after Lifting of Long-Term Prescription Ban
August 2, 2012
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
